Related Experiment Video
Updated: Jul 6, 2025

Using the E1A Minigene Tool to Study mRNA Splicing Changes
Published on: April 22, 2021
SF3B4 downregulation restrains lung adenocarcinoma tumorigenesis via 5' alternative splicing of KAT2A
Ailin Qu1, Bo Han2, Mengmeng Hua3,4
1Department of Clinical Laboratory, Qilu Hospital, Shandong University, Jinan, 250012, Shandong, China.
Abstract:
Aberrant expression of splicing factors, including SF3B4, plays a vital role in lung adenocarcinoma (LUAD). However, the impact of SF3B4 in the progression of LUAD has not been studied well. Here, we demonstrated the effects of SF3B4 in LUAD via apoptosis, proliferation, migration assays, etc. Gene manipulations confirmed the role of SF3B4 via KAT2A. SF3B4 was found to promote LUAD growth. Further studies found that, upon SF3B4 knockdown in LUAD cells, an alternative splice site occurred at the 5'-UTR of KAT2A, which led to the downregulation of KAT2A at both RNA and protein levels. Furthermore, the decrease in KAT2A expression partially reversed the effect of SF3B4 in promoting tumorigenesis. The axis SF3B4/ KAT2A was identified as a significant player in LUAD progression, shedding light on the therapeutic development in LUAD.
Insights
Aberrant splicing factor SF3B4 promotes lung adenocarcinoma (LUAD) growth by downregulating KAT2A. Targeting the SF3B4/KAT2A axis offers potential therapeutic strategies for LUAD patients.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Aberrant splicing factor expression is implicated in lung adenocarcinoma (LUAD) pathogenesis.
- The specific role of SF3B4 in LUAD progression remains incompletely understood.
Purpose of the Study:
- To investigate the functional impact of SF3B4 on LUAD development.
- To elucidate the molecular mechanisms underlying SF3B4's role in LUAD.
Main Methods:
- In vitro assays including apoptosis, proliferation, and migration assays were performed.
- Gene manipulation techniques were employed to study SF3B4 and KAT2A interactions.
- RNA and protein levels were analyzed following SF3B4 knockdown.
Main Results:
- SF3B4 was found to promote LUAD cell growth and tumorigenesis.
- SF3B4 knockdown induced an alternative splice site in KAT2A's 5'-UTR, reducing KAT2A RNA and protein levels.
- Decreased KAT2A partially counteracted the tumor-promoting effects of SF3B4.
Conclusions:
- The SF3B4/KAT2A axis is a critical regulator of LUAD progression.
- SF3B4 promotes LUAD by downregulating KAT2A expression.
- This axis presents a potential therapeutic target for lung adenocarcinoma.
Related Concept Videos
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
RNA Splicing
Abnormal Proliferation
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

